Donepezil delays progression to AD in MCI subjects with depressive symptoms
AUTOR(ES)
Lu, P H.
FONTE
American Academy of Neurology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2697965Documentos Relacionados
- The pattern of depressive symptoms varies with progression of Parkinson's disease.
- MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change
- MRI and CSF biomarkers in normal, MCI, and AD subjects: Diagnostic discrimination and cognitive correlations
- Insomnia, depressive signs and symptoms and quality of life in institutionalized elderly subjects
- Depressive Symptoms in Inner-City Children With Asthma